Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 01, 2026
Ares Management (ARES): Q1 2026 Earnings Preview – EPS Seen Rising +21.8% on Record AUM

Ares Management (ARES): Q1 2026 Earnings Preview – EPS Seen Rising +21.8% on Record AUM

Key Takeaways

  • Consensus EPS estimate stands at $1.33 for the first quarter ended March 31, 2026, reflecting a 21.8% year-over-year increase from $1.09.
  • Revenue expectations hover around $1.11 billion, driven by expanding assets under management (AUM).
  • AUM reached a record $623 billion as of December 31, 2025, up 29% from the prior year.
  • Ares has delivered mixed results recently, beating EPS estimates in two of the last four quarters.
  • Investors are focused on fee-related earnings (FRE, a key profitability metric excluding volatile performance fees) and fundraising momentum.
  • Record $113 billion raised in 2025 underscores strong demand for Ares' private credit and equity strategies.

Earnings Context and Why It Matters

Ares Management Corporation (ARES), a global leader in alternative investments, oversees $623 billion in AUM across private credit, private equity, and real estate. This earnings report for the first quarter ended March 31, 2026, feels pivotal to me because it will test the sustainability of fee revenue growth in a still-favorable environment for private markets. With interest rates stabilizing and demand for yield-enhancing assets on the rise, ARES's success in deploying capital and attracting inflows could point to the broader health of the industry. The recent record fundraising and AUM expansion demonstrate real operational strength, which makes this release essential for anyone evaluating long-term compounding through stable management fees rather than volatile performance income.

Earnings Expectations

Analysts are projecting EPS of $1.33 for Q1 2026, up from $1.09 in the year-ago quarter, drawing from estimates by 14 analysts. Revenue consensus sits at $1.11 billion from four analysts, bolstered by AUM growth and deployment activity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry, and Zacks has EPS pegged slightly higher at $1.34.

Looking back, ARES has shown variability: Q1 2025 EPS beat ($1.09 vs. $0.94 est.), Q2 missed ($1.03 vs. $1.09), Q3 beat ($1.19 vs. $1.14), and Q4 missed ($1.45 vs. $1.69). One thing that stands out is the need to watch key metrics like FRE per share, management fees, and performance revenues, which can fluctuate with realizations. Investors will likely get updates on the fundraising pipeline and capital deployment, particularly in private credit where ARES holds a strong position. No specific company guidance came last quarter, but the full-year growth outlook remains optimistic at 27.9% EPS expansion.

Market Reaction and Investor Sentiment

Heading into earnings, sentiment around ARES strikes me as cautiously optimistic, supported by record AUM and fundraising yet checked by the Q4 2025 EPS miss that caused a nearly 7% stock drop. The shares have ridden the alternative asset boom, though volatility in performance fees remains a risk. Key factors like surprises in FRE growth or guidance could drive reactions, especially given how historical beats in core metrics have amplified moves.

Tools I Use: Tickeron’s AI Screener

One tool I rely on regularly for this kind of analysis is Tickeron’s AI Screener, an AI-powered stock and ETF discovery platform. It lets me filter thousands of stocks and ETFs using customizable criteria like industry, market cap, technical indicators, price patterns, and performance metrics, helping spot trade ideas, trending stocks, or breakout candidates far more efficiently than manual methods. From what I see, it’s a practical way to enhance my investment strategy without getting bogged down in spreadsheets.

Forward Outlook and Key Factors to Monitor

After Q1 results, I’ll be tracking management’s full-year guidance closely, especially on fee revenue trajectory and AUM expansion. ARES's record fundraising in 2025 sets it up well for steady inflows, but sustained deployment in a competitive private markets landscape will be crucial. I’m also watching Tickeron’s AI Trend Prediction Engine for signals on momentum here.

Private credit continues as a bright spot, drawing institutional capital with its higher yields. Keep an eye on portfolio performance, unrealized marks, and cost management, since margin pressures from compensation could affect profitability.

Broader factors like interest rate paths and regulatory shifts in alternatives will shape the outlook. Upcoming catalysts might include secondary fundraising announcements and peer comparisons in asset management. For long-term insights, I focus on recurring revenue stability over one-off performance fees.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ARES

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ARES's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for ARES moved out of overbought territory on August 14, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 instances where the indicator moved out of the overbought zone. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where ARES's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ARES turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARES declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARES broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 19, 2026. You may want to consider a long position or call options on ARES as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ARES moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ARES crossed bullishly above the 50-day moving average on July 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARES advanced for three days, in of 349 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 283 cases where ARES Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARES's P/B Ratio (12.706) is slightly higher than the industry average of (3.525). ARES has a moderately high P/E Ratio (64.794) as compared to the industry average of (27.186). Projected Growth (PEG Ratio) (1.334) is also within normal values, averaging (1.208). Dividend Yield (0.035) settles around the average of (0.086) among similar stocks. P/S Ratio (5.258) is also within normal values, averaging (16.512).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARES’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 9.63B. The market cap for tickers in the group ranges from 57 to 179.11B. BLK holds the highest valuation in this group at 179.11B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 2%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 5%. ZSTK experienced the highest price growth at 143%, while AMBR experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was -4%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 55
Price Growth Rating: 51
SMR Rating: 74
Profit Risk Rating: 78
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
ARES
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of investment advice services

Industry InvestmentManagers

Profile
Details
Industry
Investment Managers
Address
2000 Avenue of the Stars
Phone
+1 310 201-4100
Employees
2850
Web
https://www.aresmgmt.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.